 | | Etravirine (Intelence, TMC 125) |  | | Published
February 12, 2008; Updated
March 2013 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-02-04 | | | Selected Reference | | 6. | Ruxrungtham K, Pedro RJ, Latiff GH, et al; TMC125-C227 Study Group. Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naive, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227. HIV Med. 2008 Nov;9(10):883-96. | |
|
|
|
